Results 91 to 100 of about 25,524 (191)

Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

Drugs - Real World Outcomes
Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years.
Misaki Tokunaga, Daisuke Kikuchi, Aoi Noda, Sachiko Oikawa, Makoto Shiozawa, Hiroaki Hino, Ryosuke Miura, Kensuke Usui, Taku Obara, Kouji Okada   +9 more
doaj   +1 more source

Efficacy and safety of intravenous peramivir versus oral oseltamivir in the treatment of influenza in children: A meta-analysis

Journal of Clinical Virology Plus
Objective: To investigate the efficacy and safety of intravenous peramivir compared to oral oseltamivir for pediatric influenza by a method of meta-analysis.
Jie Yuan, Shuhua An, Zhongfu Zhang
doaj   +1 more source

Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses [PDF]

, 2015
Ashona Singh, Mahmoud E Soliman School of Health Sciences, University of KwaZulu-Natal, Westville, Durban, South Africa Abstract: This study embarks on a comprehensive description of the conformational contributions to resistance of neuraminidase (N1 ...
Soliman ME, Singh A
core  

Live-focus fluorescence imaging of oseltamivir-resistant virus.

, 2016
MDCK cells on a 12-well plate were infected with oseltamivir-resistant 738 or oseltamivir-sensitive 838. The cells were cultured in an SFM containing 0.5% agarose and 2 μg/ml acetylated trypsin.
Yuuki Kurebayashi (235568), Keiji Sahara (3167001), Kiyoshi Ikeda (508348), Chihiro Tamoto (3167004), Tadanobu Takahashi (235567), Tadamune Otsubo (508346), Nona Shibahara (832839), Hirohisa Wada (832844), Takashi Suzuki (8491), Tatsuya Yokozawa (3167007), Akira Minami (474027)   +10 more
core   +1 more source

In Silico Profiling of Binding Affinities of Hybrid Molecules of Oseltamivir carboxamides cross-linked with Hydroxamic acid as possible Anti-influenza agents

Al-Mustansiriyah Journal of Pharmaceutical Sciences
Influenza is an infectious respiratory disease caused by the influenza virus and is a significant global public health concern. This infection displays a tendency for recurring outbreaks during specific seasons and occasional epidemics.
Sumia Samer Tayah, Shakir Mahmood Alwan, Kenza Mansoor   +2 more
doaj   +1 more source

Peran Penggunaan Oseltamivir pada Pasien Coronavirus Disease 2019 : Literature Review [PDF]

, 2020
Coronavirus disease 2019 (COVID-19) is a disease caused by novel coronavirus called SARS-CoV-2. This virus has infected many countries and spread rapidly around the world. However, there is no spesific drugs to treat COVID-19.
Eka Pertiwi
core  

Effect of Oseltamivir Use on Follow-Up Stroke Mortality

Pharmaceuticals
Background/Objectives: Evidence has indicated an increased risk of stroke in individuals with influenza infection, and the administration of Oseltamivir revealed a lower stroke risk in these individuals.
Pei-Hua Chuang, Bor-Show Tzang, Chih-Chen Tzang, I-Ying Kuo, Chun-Yu Lin, Tsai-Ching Hsu   +5 more
doaj   +1 more source

Oseltamivir utilization during the 2009 H1N1 influenza pandemic, Taiwan

, 2013
2009年3月起，H1N1新型流感病毒從墨西哥與美國開始，散播至全世界造成流感大流行。流感抗病毒藥物被建議使用在所有疑似或確診為流感的病人，特別是容易產生併發症之高危險族群。其中以oseltamivir最廣為被使用。台灣全民健康保險於此波大流行期間給付流感抗原快速篩檢以及oseltamivir藥物。oseltamivir藥物利用，尤其在不同年齡層與地區的差異是重要的議題。此外關於大量使用oseltamivir之效果，藥物安全與抗藥性病毒的問題也引起大眾關注。 本研究利用2009年台灣全民健保資料庫 ...
Su, Chia-Ping, 蘇家彬
core  

Combinations of L-N^G-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice

, 2017
L-NG-monomethyl-arginine (L-NMMA) is an experimental compound that suppresses nitric oxide production in animals. The compound was combined with oseltamivir to treat lethal influenza A/California/04/2009 (H1N1) pandemic virus infections in mice ...
Ashley Dagley, EB Tarbet, Donald F Smee
core   +1 more source

Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system.

PLoS ONE
Assessing the potential for oseltamivir-induced liver damage is essential to ensure its safe administration. The aim of this study was to examine the association between hepatotoxicity and oseltamivir use and to describe the features of oseltamivir ...
Lurong Yu, Qiumeng Xiang, Limei Liu
doaj   +1 more source